CLINICAL_TRIALS
trial_result
· 2014-07-14
Clinical Trial Update: WAL801CL (Epinastine Hydrochloride) Dry Syrup in Paediatric Perennial Allergic Rhinitis [Phase 3]
Summary
A Phase 3 clinical trial evaluating WAL801CL (epinastine hydrochloride) dry syrup in pediatric perennial allergic rhinitis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Rhinitis, Allergic, Perennial | Phase 3 | Status: COMPLETED